TOMI Environmental Solutions, Inc. (TOMZ) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. TOMI Environmental Solutions, Inc. is a global provider of disinfection and decontamination solutions utilizing its proprietary Binary Ionization Technology (BIT) under the SteraMist brand. The company operates across five divisions: Life Sciences, Healthcare, TOMI Service Network, Food Safety, and Commercial. The company is classified as a non-accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | Q2 2023 (3 Months) | YTD 2024 (6 Months) | YTD 2023 (6 Months) |
|---|---|---|---|---|
| Net Revenue | $3,013,392 | $2,774,699 | $4,127,479 | $4,356,871 |
| Gross Profit | $1,854,516 | $1,700,279 | $2,525,184 | $2,641,516 |
| Gross Margin | 61.5% | 61.3% | 61.2% | 60.6% |
| Net Income (Loss) | $30,198 | $(88,591) | $(1,279,992) | $(1,276,078) |
| Operating Income (Loss) | $121,812 | $(88,940) | $(1,104,664) | $(1,277,086) |
| Cash and Equivalents | $709,110 (as of June 30, 2024) | |||
| Working Capital | $6,828,347 (as of June 30, 2024) | |||
| Convertible Notes Payable | $2,329,254 (net of discount) |
Material Changes vs. Prior Period
- Profitability Milestone: The company reported a net profit of approximately $30,000 for Q2 2024, marking the first profitable quarter since the end of 2020. This contrasts with a net loss of $88,591 in Q2 2023.
- Revenue Growth: Q2 2024 revenue increased 9% year-over-year (YoY) and grew 170% sequentially from Q1 2024. International revenue surged 130% YoY, driven by new customers in Canada, Mexico, the Philippines, and the UAE.
- Product Mix Shift: Mobile SteraMist equipment accounted for over 60% of revenue in Q2 2024, a product mix not seen since 2022. Conversely, service and training revenue declined 43% YoY due to the timing of emergency service work.
- Expense Management: Total operating expenses decreased 3% YoY and 9% sequentially due to cost-reduction initiatives, including a 30% reduction in executive cash compensation and termination of select consulting agreements.
- Liquidity: Cash and cash equivalents decreased from $2.34 million at year-end 2023 to $709,110 at June 30, 2024, primarily due to net cash used in operating activities of $1.56 million for the six-month period.
Guidance, Outlook, and Risks
- Strategic Partnerships: The company announced a partnership with EMAQ Group, which invested over $1 million in equipment to expand services in the western U.S. New corporate service contracts were secured with entities including the University of Texas, Rising Pharmaceutical, Cornell, and GlaxoSmithKline.
- Product Pipeline: Management highlighted the growth of Custom Engineered Systems (CES) and the new SteraMist Hybrid and Transport units. A backlog of approximately $1 million was reported as of June 30, 2024.
- Liquidity Outlook: Management believes existing cash and expected operational cash flows are sufficient to meet requirements for the next 12 months. However, the company may require additional liquidity to continue operations absent other actions, with plans to raise capital through equity/debt offerings and government grants.
- Risks: Key risks include customer concentration (two customers accounted for 54% of Q2 revenue), reliance on a limited number of vendors (one vendor accounted for 55% of accounts payable), and the potential dilution of shareholders from future financing or convertible debt exercises.
Investor Verification Checklist
- Cash Burn Rate: Verify the sustainability of operations given the drop in cash reserves to ~$709k and the continued negative operating cash flow of $1.56M for the first half of the year.
- Revenue Concentration: Assess the risk associated with two customers representing 54% of Q2 revenue and three customers representing 44% of gross accounts receivable.
- Debt Obligations: Review the terms of the $2.6 million convertible notes (12% interest, convertible at $1.25/share) and the potential for dilution if the stock price exceeds the conversion trigger.
- Service Revenue Volatility: Monitor the significant decline in service revenue (-43% YoY) to determine if this is a temporary timing issue or a structural shift in the business model.
- Cost Reduction Sustainability: Confirm if the 30% executive compensation reduction and consulting cuts are permanent measures or temporary adjustments.